Search and Filter
Results per Page:
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch
Good News: $8.8 million NIH grant; Evergreen Fund to accelerate commercialization of research; Hutch United co-chair receives fellowship
Celebrating faculty and staff achievements
Burkitt's Lymphoma Fund for Africa partners with Fred Hutch to carry on its founder's passion
Partnering with Fred Hutch Global Oncology, Burkitt’s Lymphoma Fund for Africa carries on its founder’s passion
Fred Hutch/SCCA transplant rates among best in U.S.
Fred Hutch Bone Marrow Transplant Program recognized for outperforming expected one-year survival rates for allogeneic transplant patients
A Q&A with evolutionary, computational biologist Trevor Bedford
'Trying to be useful instead of trying to be clever': An evolutionary biologist-virologist-immunologist-computer-wonk finds his niche
Experimental herpes drug pritelivir more effective than standard treatment
Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows
What's new in blood diseases
Four things to watch from the 2016 annual meeting of the American Society of Hematology
‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science
Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
The ‘cancer Olympics’: Why envy, rivalry exist among some patients
Survivors often compare their cancers — a normal yet potentially unhealthy exercise, experts say
Fred Hutch physician-scientist’s memoir sheds light on relationships with parents, food and our bodies
Dr. Anne McTiernan nearly starved to death at age 4 — then she grew up to be a nutrition researcher. Her new memoir focuses on the path between.
'A place where miracles happen': Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science
Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
A new blood test detects recurrence of rare skin cancer
$200 assay can accurately signal return of Merkel cell carcinoma — in some cases catching tumors earlier than expensive imaging
Good News: $475K gift fuels expansion of antibody tech; Hansen honored for BMT work; Senate passes 21st Century Cures Act
Celebrating faculty and staff achievements
The quest to better understand the deadliest childhood leukemia
Oncologists are beginning to leverage unique genomic characteristics of pediatric AML to improve treatment and prognosis
Fred Hutch holiday gala raises more than $13 million for pediatric cancer research
Fred Hutch Holiday Gala brings in more than $13 million to grow pediatric cancer research and develop needed therapies for children
Immunotherapy shows promise in preventing leukemia relapse
Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission after more than two years
Sorting stem cells before transplant helps lower risk of graft-vs.-host disease, researcher reports at ASH
Sorting stem cells before transplant helps lower the risk of graft-vs.-host disease, researcher reports
Three's a charm in a triple-drug combination for transplant patients
A drug with a storied past offers a new edge against an old foe
‘Can’t sit and wait’: Gene therapy trial aims to cure rare Fanconi anemia
At annual hematology meeting, Fred Hutch researchers updated their treatment of 11-year-old Behzad
In Uganda, strengthening a partnership against cancer
A ‘compelling and inspiring visit’ yields renewed commitment by Fred Hutch, Ugandan leaders